Yash Joshi

Title(s)Assistant Professor in Residence, Psychiatry
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A qualitative analysis of participant experience during an EEG-linked auditory targeted cognitive training exercise: Implications for implementation and protocol optimization. Psychiatry Res. 2024 Oct 28; 342:116254. Conroy C, Li F, Sprock J, Rabin BA, Joshi YB. PMID: 39504613.
      View in: PubMed   Mentions:    Fields:    
    2. Early auditory processing abnormalities alter individual learning trajectories and sensitivity to computerized cognitive training in schizophrenia. Psychol Med. 2024 Jul; 54(10):2669-2676. Molina JL, Joshi YB, Nungaray JA, Sprock J, Attarha M, Biagianti B, Thomas ML, Swerdlow NR, Light GA. PMID: 38587021.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Clarifying directional dependence among measures of early auditory processing and cognition in schizophrenia: leveraging Gaussian graphical models and Bayesian networks. Psychol Med. 2024 Jul; 54(9):1930-1939. Abplanalp SJ, Braff DL, Light GA, Joshi YB, Nuechterlein KH, Green MF, Consortium on the Genetics of Schizophrenia. PMID: 38287656; PMCID: PMC11413352.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Points that Need Attention in Early Auditory Information Processing Research in Schizophrenia: Response to Lin and Hsieh. Am J Psychiatry. 2023 11 01; 180(11):841-842. Joshi Y, Swerdlow N, Light G. PMID: 37908092.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Click-train evoked steady state harmonic response as a novel pharmacodynamic biomarker of cortical oscillatory synchrony. Neuropharmacology. 2023 Dec 01; 240:109707. Gautam D, Raza MU, Miyakoshi M, Molina JL, Joshi YB, Clayson PE, Light GA, Swerdlow NR, Sivarao DV. PMID: 37673332.
      View in: PubMed   Mentions: 2     Fields:    
    6. Effects of Memantine on the Auditory Steady-State and Harmonic Responses to 40 Hz Stimulation Across Species. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 Mar; 9(3):346-355. Swerdlow NR, Gonzalez CE, Raza MU, Gautam D, Miyakoshi M, Clayson PE, Joshi YB, Molina JL, Talledo J, Thomas ML, Light GA, Sivarao DV. PMID: 37683728.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    7. Mismatch negativity predicts initial auditory-based targeted cognitive training performance in a heterogeneous population across psychiatric disorders. Psychiatry Res. 2023 09; 327:115215. Joshi YB, Gonzalez CE, Molina JL, MacDonald LR, Min Din J, Minhas J, Leposke T, Nordberg B, Li F, Talledo J, Sprock J, Swerdlow NR, Light GA. PMID: 37406367.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Sensitivity of Schizophrenia Endophenotype Biomarkers to Anticholinergic Medication Burden. Am J Psychiatry. 2023 07 01; 180(7):519-523. Joshi YB, Molina JL, Braff DL, Green MF, Gur RC, Gur RE, Nuechterlein KH, Stone WS, Greenwood TA, Lazzeroni LC, Radant AD, Silverman JM, Sprock J, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Swerdlow NR, Light GA. PMID: 37038743.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Preliminary Evidence that Memantine Enhances Prepulse Effects on Startle Magnitude and Latency in Patients with Alzheimer's Disease. J Alzheimers Dis. 2023; 91(1):355-362. Swerdlow NR, Joshi YB, Sprock J, Talledo J, Molina JL, Delano-Wood L, Iwanaga D, Kotz JE, Huege S, Léger GC, Light GA. PMID: 36404550.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Cholinergic Functioning, Cognition, and Anticholinergic Medication Burden in Schizophrenia. Curr Top Behav Neurosci. 2023; 63:393-406. Joshi YB. PMID: 36441495.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    11. Evaluation of the frequency following response as a predictive biomarker of response to cognitive training in schizophrenia. Psychiatry Res. 2021 11; 305:114239. Clayson PE, Molina JL, Joshi YB, Thomas ML, Sprock J, Nungaray J, Swerdlow NR, Light GA. PMID: 34673326.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Central auditory processing deficits in schizophrenia: Effects of auditory-based cognitive training. Schizophr Res. 2021 10; 236:135-141. Molina JL, Joshi YB, Nungaray JA, Thomas ML, Sprock J, Clayson PE, Sanchez VA, Attarha M, Biagianti B, Swerdlow NR, Light GA. PMID: 34500174; PMCID: PMC9259506.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. The viability of the frequency following response characteristics for use as biomarkers of cognitive therapeutics in schizophrenia. Schizophr Res. 2022 05; 243:372-382. Clayson PE, Joshi YB, Thomas ML, Tarasenko M, Bismark A, Sprock J, Nungaray J, Cardoso L, Wynn JK, Swerdlow NR, Light GA. PMID: 34187732.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    14. Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia. Am J Psychiatry. 2021 09 01; 178(9):838-847. Joshi YB, Thomas ML, Braff DL, Green MF, Gur RC, Gur RE, Nuechterlein KH, Stone WS, Greenwood TA, Lazzeroni LC, MacDonald LR, Molina JL, Nungaray JA, Radant AD, Silverman JM, Sprock J, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Swerdlow NR, Light GA. PMID: 33985348; PMCID: PMC8440496.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    15. Abnormal phase discontinuity of alpha- and theta-frequency oscillations in schizophrenia. Schizophr Res. 2021 05; 231:73-81. Koshiyama D, Miyakoshi M, Tanaka-Koshiyama K, Joshi YB, Sprock J, Braff DL, Light GA. PMID: 33780847; PMCID: PMC8222093.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    16. Hierarchical Pathways from Sensory Processing to Cognitive, Clinical, and Functional Impairments in Schizophrenia. Schizophr Bull. 2021 03 16; 47(2):373-385. Koshiyama D, Thomas ML, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. PMID: 32856089; PMCID: PMC7965084.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    17. Source decomposition of the frontocentral auditory steady-state gamma band response in schizophrenia patients and healthy subjects. Psychiatry Clin Neurosci. 2021 May; 75(5):172-179. Koshiyama D, Miyakoshi M, Joshi YB, Nakanishi M, Tanaka-Koshiyama K, Sprock J, Light GA. PMID: 33470494.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    18. Unique contributions of sensory discrimination and gamma synchronization deficits to cognitive, clinical, and psychosocial functional impairments in schizophrenia. Schizophr Res. 2021 02; 228:280-287. Koshiyama D, Miyakoshi M, Thomas ML, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. PMID: 33493776.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    19. Sources of the frontocentral mismatch negativity and P3a responses in schizophrenia patients and healthy comparison subjects. Int J Psychophysiol. 2021 03; 161:76-85. Koshiyama D, Miyakoshi M, Joshi YB, Nakanishi M, Tanaka-Koshiyama K, Sprock J, Light GA. PMID: 33453303; PMCID: PMC8099045.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Using Biomarkers to Predict Memantine Effects in Alzheimer's Disease: A Proposal and Proof-Of-Concept Demonstration. J Alzheimers Dis. 2021; 84(4):1431-1438. Swerdlow NR, Kotz JE, Joshi YB, Talledo J, Sprock J, Molina JL, Huisa B, Huege SF, Romero JA, Walsh MJ, Delano-Wood L, Light GA. PMID: 34690144; PMCID: PMC8881988.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. Neural network dynamics underlying gamma synchronization deficits in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2021 04 20; 107:110224. Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Braff DL, Swerdlow NR, Light GA. PMID: 33340619; PMCID: PMC8631608.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    22. Neurophysiologic Characterization of Resting State Connectivity Abnormalities in Schizophrenia Patients. Front Psychiatry. 2020; 11:608154. Koshiyama D, Miyakoshi M, Tanaka-Koshiyama K, Joshi YB, Molina JL, Sprock J, Braff DL, Light GA. PMID: 33329160; PMCID: PMC7729083.
      View in: PubMed   Mentions: 7  
    23. Gamma oscillations predict pro-cognitive and clinical response to auditory-based cognitive training in schizophrenia. Transl Psychiatry. 2020 11 23; 10(1):405. Molina JL, Thomas ML, Joshi YB, Hochberger WC, Koshiyama D, Nungaray JA, Cardoso L, Sprock J, Braff DL, Swerdlow NR, Light GA. PMID: 33230190; PMCID: PMC7684295.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    24. Memantine effects on auditory discrimination and training in schizophrenia patients. Neuropsychopharmacology. 2020 12; 45(13):2180-2188. Swerdlow NR, Bhakta SG, Talledo J, Kotz J, Roberts BZ, Clifford RE, Thomas ML, Joshi YB, Molina JL, Light GA. PMID: 32961542; PMCID: PMC7784956.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    25. Abnormal Spontaneous Gamma Power Is Associated With Verbal Learning and Memory Dysfunction in Schizophrenia. Front Psychiatry. 2020; 11:832. Tanaka-Koshiyama K, Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Sprock J, Braff DL, Light GA. PMID: 33110410; PMCID: PMC7488980.
      View in: PubMed   Mentions: 19  
    26. A distributed frontotemporal network underlies gamma-band synchronization impairments in schizophrenia patients. Neuropsychopharmacology. 2020 12; 45(13):2198-2206. Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. PMID: 32829382; PMCID: PMC7784692.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    27. Contextualizing the road to recovery: A novel method of assessing outcome trajectories in clinical trials. Psychol Serv. 2021 Nov; 18(4):554-565. Treichler EBH, Cardoso L, Du Y, Nungaray J, Hochberger WC, Joshi YB, Sprock J, Cohen AN, Light GA. PMID: 32658511.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    28. Abnormal Effective Connectivity Underlying Auditory Mismatch Negativity Impairments in Schizophrenia. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 11; 5(11):1028-1039. Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. PMID: 32830097.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    29. Memantine Effects on Electroencephalographic Measures of Putative Excitatory/Inhibitory Balance in Schizophrenia. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 06; 5(6):562-568. Molina JL, Voytek B, Thomas ML, Joshi YB, Bhakta SG, Talledo JA, Swerdlow NR, Light GA. PMID: 32340927; PMCID: PMC7286803.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    30. Oscillatory biomarkers of early auditory information processing predict cognitive gains following targeted cognitive training in schizophrenia patients. Schizophr Res. 2020 01; 215:97-104. Hochberger WC, Thomas ML, Joshi YB, Molina J, Treichler EBH, Nungaray J, Cardoso L, Sprock J, Swerdlow N, Light GA. PMID: 31759809; PMCID: PMC7035985.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    31. Deviation from expected cognitive ability is a core cognitive feature of schizophrenia related to neurophysiologic, clinical and psychosocial functioning. Schizophr Res. 2020 01; 215:300-307. Hochberger WC, Thomas ML, Joshi YB, Swerdlow NR, Braff DL, Gur RE, Gur RC, Light GA, Consortium of Genomics in Schizophrenia (COGS) investigators. PMID: 31744751.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    32. Verbal learning deficits associated with increased anticholinergic burden are attenuated with targeted cognitive training in treatment refractory schizophrenia patients. Schizophr Res. 2019 06; 208:384-389. Joshi YB, Thomas ML, Hochberger WC, Bismark AW, Treichler EBH, Molina J, Nungaray J, Cardoso L, Sprock J, Swerdlow NR, Light GA. PMID: 30738698; PMCID: PMC8215853.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    33. Divergence of subjective and performance-based cognitive gains following cognitive training in schizophrenia. Schizophr Res. 2019 08; 210:215-220. Treichler EBH, Thomas ML, Bismark AW, Hochberger WC, Tarasenko M, Nungaray J, Cardoso L, Joshi YB, Zhang W, Sprock J, Swerdlow N, Cohen AN, Light GA. PMID: 30660574; PMCID: PMC7032664.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    34. Decomposing the constituent oscillatory dynamics underlying mismatch negativity generation in schizophrenia: Distinct relationships to clinical and cognitive functioning. Int J Psychophysiol. 2019 11; 145:23-29. Hochberger WC, Joshi YB, Zhang W, Thomas ML, Consortium of Genomics in Schizophrenia (COGS) investigators, Braff DL, Swerdlow NR, Light GA. PMID: 30586570; PMCID: PMC7261144.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    35. Using EEG-Guided Basket and Umbrella Trials in Psychiatry: A Precision Medicine Approach for Cognitive Impairment in Schizophrenia. Front Psychiatry. 2018; 9:554. Joshi YB, Light GA. PMID: 30510520; PMCID: PMC6252381.
      View in: PubMed   Mentions: 5  
    36. Neurophysiologic measures of target engagement predict response to auditory-based cognitive training in treatment refractory schizophrenia. Neuropsychopharmacology. 2019 02; 44(3):606-612. Hochberger WC, Joshi YB, Thomas ML, Zhang W, Bismark AW, Treichler EBH, Tarasenko M, Nungaray J, Sprock J, Cardoso L, Swerdlow N, Light GA. PMID: 30377381; PMCID: PMC6333927.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    37. Targeted cognitive training improves auditory and verbal outcomes among treatment refractory schizophrenia patients mandated to residential care. Schizophr Res. 2018 12; 202:378-384. Thomas ML, Bismark AW, Joshi YB, Tarasenko M, Treichler EBH, Hochberger WC, Zhang W, Nungaray J, Sprock J, Cardoso L, Tiernan K, Attarha M, Braff DL, Vinogradov S, Swerdlow N, Light GA. PMID: 30055883; PMCID: PMC7409526.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    38. Computerized cognitive training is associated with improved psychosocial treatment engagement in schizophrenia. Schizophr Res. 2018 12; 202:341-346. Thomas ML, Treichler EBH, Bismark A, Shiluk AL, Tarasenko M, Zhang W, Joshi YB, Sprock J, Cardoso L, Tiernan K, Light GA. PMID: 29929773; PMCID: PMC7409521.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    39. Mismatch negativity impairment is associated with deficits in identifying real-world environmental sounds in schizophrenia. Schizophr Res. 2018 01; 191:5-9. Joshi YB, Breitenstein B, Tarasenko M, Thomas ML, Chang WL, Sprock J, Sharp RF, Light GA. PMID: 28927552; PMCID: PMC6697420.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    40. Dissociative Intoxication and Prolonged Withdrawal Associated With Phenibut: A Case Report. J Clin Psychopharmacol. 2017 08; 37(4):478-480. Joshi YB, Friend SF, Jimenez B, Steiger LR. PMID: 28614159; PMCID: PMC5662439.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    41. Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia. Neuropsychopharmacology. 2017 Dec; 42(13):2633-2639. Light GA, Zhang W, Joshi YB, Bhakta S, Talledo JA, Swerdlow NR. PMID: 28425497; PMCID: PMC5686499.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    42. Atypical Neuroleptic Malignant Syndrome Associated With Paliperidone Long-Acting Injection: A Case Report. J Clin Psychopharmacol. 2016 Jun; 36(3):277-9. Langley-DeGroot M, Joshi Y, Lehman D, Rao S. PMID: 27043124.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    Yash's Networks
    Concepts (89)
    Derived automatically from this person's publications.
    _
    Co-Authors (21)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _